STOCK TITAN

Crescent Capital Bdc Inc 8-K Filings

CCAP NASDAQ

Every 8-K that Crescent Capital Bdc Inc (CCAP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow CCAP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCAP filings page.

Rhea-AI Summary

Crescent Capital BDC, Inc. reported second quarter 2026 results for the quarter ended June 30, 2026. Net investment income was $13.1 million, or $0.36 per share, while net income was a loss of $0.09 per share, reflecting net realized and unrealized losses on investments.

Total investment income was $36.3 million, down from $37.9 million in the prior quarter and $43.0 million a year earlier, mainly due to lower dividend income from its Logan JV and reduced accelerated amortization and prepayment fee income. Net asset value was $656.5 million, or $17.82 per share, compared with $19.55 a year earlier.

The investment portfolio had a fair value of $1,570.7 million across 192 portfolio companies, with 98.4% of debt investments at floating rates and a weighted average yield on income-producing securities of 9.6%. The board declared a third quarter 2026 regular cash dividend of $0.34 per share and the second of three $0.03 per share special dividends. Liquidity at June 30, 2026 included $35.7 million in cash and $199.6 million of undrawn credit capacity, with a net debt-to-equity ratio of 1.37x.

Rhea-AI Summary

Crescent Capital BDC, Inc. prepaid its 7.54% senior unsecured notes ahead of maturity. The company paid approximately $51.6 million, covering the $50.0 million aggregate principal amount plus accrued and unpaid interest, to retire notes that were due on July 28, 2026. After this transaction, none of these notes remain outstanding, meaning this specific debt obligation has been fully eliminated.

Rhea-AI Summary

Crescent Capital BDC, Inc. increased borrowing capacity under its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation. Dollar commitments under the SMBC Corporate Revolving Facility rose from $140 million to $165 million, and the maximum principal amount increased from $310 million to $335 million. All other terms of the facility remained unchanged.

Rhea-AI Summary

Crescent Capital BDC, Inc. updated its borrowing and note financing structure. A subsidiary entered a Ninth Amendment with Wells Fargo that increases its credit facility size from $400.0 million to $500.0 million, slightly raises the interest spread from 1.95% to 2.00%, extends the reinvestment period to May 21, 2029 and the stated maturity to May 21, 2031, and reduces the non-usage fee from 0.50% to 0.35%.

The company also completed previously announced private note issuances, including $50.0 million of Tranche C senior unsecured notes bearing 5.97% interest and maturing on May 22, 2029. In connection with these actions, on May 22, 2026 the company repaid $111.6 million of FCRX 5.00% unsecured notes in full, signaling a shift in its debt mix and maturity profile.

Rhea-AI Summary

Crescent Capital BDC, Inc. held its 2026 annual stockholder meeting, where 36,969,285 common shares were entitled to vote as of March 18, 2026. Stockholders elected Susan Yun Lee and Michael S. Segal as Class II directors to terms running through the 2029 annual meeting. Lee received 17,107,252 votes for, 306,098 against, and 107,901 abstentions. Segal received 16,302,024 votes for, 1,113,132 against, and 106,095 abstentions. Shareholders also ratified Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 26,529,354 votes for, 211,437 against, and 155,426 abstentions.

Rhea-AI Summary

Crescent Capital BDC, Inc. reported first quarter 2026 net investment income of $0.42 per share and a net loss of $0.42 per share, reflecting realized and unrealized losses on investments. Net asset value per share declined to $18.27 from $19.10 at year-end 2025.

The Board declared a regular second quarter 2026 cash dividend of $0.34 per share and special cash dividends totaling $0.09 per share, payable in three $0.03 installments. After quarter-end, the company reduced its base management fee to 1.00% and incentive fee to 15.0%, aiming to better align economics with shareholders.

Rhea-AI Summary

Crescent Capital BDC, Inc. reported board changes. Effective May 5, 2026, the board accepted the resignation of Class III director Elizabeth Ko, who stated her decision was not due to any disagreement with management, the board, or company operations.

Effective May 7, 2026, the board elected Chief Executive Officer Jason Breaux and President Henry Chung as Class III directors, whose terms run until the 2027 annual meeting or until successors are elected and qualified. Breaux will serve as Chairman of the Board. Neither Breaux nor Chung will receive compensation or equity awards for board service, and both will continue in their existing executive roles.

Rhea-AI Summary

Crescent Capital BDC, Inc. has issued two new series of senior unsecured notes and arranged a third under a note purchase supplement. The supplement covers up to $67.5 million of Tranche A notes due February 13, 2029, $67.5 million of Tranche B notes due February 13, 2031, and $50.0 million of Tranche C notes due May 22, 2029.

The Tranche A notes carry a fixed rate of 5.87% and the Tranche B notes a fixed rate of 6.20%. The Tranche A and Tranche B notes were issued on February 13, 2026, while issuance of the Tranche C notes is expected on May 22, 2026, subject to customary closing conditions.

To manage interest exposure, the company entered into interest rate swaps on each of Tranche A and Tranche B for notional amounts of $67.5 million. For Tranche A it will receive fixed 5.87% and pay three month term SOFR plus 2.5325% through February 13, 2029. For Tranche B it will receive fixed 6.20% and pay three month term SOFR plus 2.8050% through February 13, 2031.

Rhea-AI Summary

Crescent Capital BDC, Inc. reported lower results for the year ended December 31, 2025, with net investment income of $1.81 per share and net income of $0.93 per share, down from $2.40 and $1.99 per share in 2024. Investment income fell to $167.3 million from $197.4 million, mainly because benchmark interest rates declined and certain debt investments were restructured. Net asset value per share declined to $19.10 from $19.98 as credit marks and foreign currency hedges weighed on results. For the fourth quarter of 2025, net investment income was $0.45 per share and net income was $0.23 per share. The company’s board declared a regular cash dividend of $0.42 per share for the first quarter of 2026, payable April 15, 2026 to shareholders of record on March 31, 2026. At year-end, Crescent BDC held $1.57 billion of investments across 184 portfolio companies, a weighted average yield on income-producing securities of 10.0%, and a debt-to-equity ratio of 1.25x, supported by $31.5 million of cash and $242.0 million of undrawn credit capacity.

Rhea-AI Summary

Crescent Capital BDC, Inc. filed an 8-K to report that it issued a press release with its financial results for the quarter ended September 30, 2025. The company furnished the full text of this earnings press release as Exhibit 99.1. The information in this section, including the exhibit, is being treated as furnished rather than filed under securities law, which affects how it is incorporated into other regulatory documents.

Rhea-AI Summary

Crescent Capital BDC, Inc. entered into a Fourth Supplement to its Note Purchase Agreement to issue senior unsecured notes in three tranches: up to $67.5 million Tranche A at 5.87% due February 13, 2029; up to $67.5 million Tranche B at 6.20% due February 13, 2031; and $50.0 million Tranche C at 5.97% due May 22, 2029.

Interest is payable semiannually on February 13 and August 13, starting February 13, 2026. Issuances will occur in two closings on or before May 22, 2026, with Tranches A and B expected on or before February 16, 2026 and Tranche C on May 22, 2026, subject to customary closing conditions. The notes are general unsecured obligations ranking pari passu with other unsecured unsubordinated debt and include a change of control offer to repay at par. The company intends to use net proceeds to repay certain indebtedness and for general corporate purposes, with potential re-borrowing under its debt facilities.